1.1 Articolo in rivista: [35986] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 2.921 a 2.940 di 35.986
Titolo Data di pubblicazione Autore(i) File
Transversal psoas muscle thickness measurement is associated with response and survival in patients with HCC undergoing immunotherapy 1-gen-2023 Scheiner, B.; Lampichler, K.; Pomej, K.; Beer, L.; Balcar, L.; Sartoris, R.; Bouattour, M.; Sidali, S.; Trauner, M.; Mandorfer, M.; Reiberger, T.; Scharitzer, M.; Tamandl, D.; Pinato, D. J.; Ronot, M.; Pinter, M.
Merits and boundaries of the BCLC staging and treatment algorithm: Learning from the past to improve the future with a novel proposal 1-gen-2024 Trevisani, F.; Vitale, A.; Kudo, M.; Kulik, L.; Park, J. -W.; Pinato, D. J.; Cillo, U.
A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinoma 1-gen-2024 Balcar, L.; Scheiner, B.; Fulgenzi, C. A. M.; D'Alessio, A.; Pomej, K.; Roig, M. B.; Meyer, E. L.; Che, J.; Nishida, N.; Lee, P. -C.; Wu, L.; Ang, C.; Krall, A.; Saeed, A.; Stefanini, B.; Cammarota, A.; Pressiani, T.; Abugabal, Y. I.; Chamseddine, S.; Wietharn, B.; Parisi, A.; Huang, Y. -H.; Phen, S.; Vivaldi, C.; Salani, F.; Masi, G.; Bettinger, D.; Vogel, A.; von Felden, J.; Schulze, K.; Silletta, M.; Trauner, M.; Samson, A.; Wege, H.; Piscaglia, F.; Galle, P. R.; Stauber, R.; Kudo, M.; Singal, A. G.; Itani, A.; Ulahannan, S. V.; Parikh, N. D.; Cortellini, A.; Kaseb, A.; Rimassa, L.; Chon, H. J.; Pinato, D. J.; Pinter, M.
Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer 1-gen-2023 Naqash, A. R.; Mccallen, J. D.; Mi, E.; Iivanainen, S.; Marie, M. A.; Gramenitskaya, D.; Clark, J.; Koivunen, J. P.; Macherla, S.; Jonnalagadda, S.; Polsani, S.; Jiwani, R. A.; Hafiz, M.; Muzaffar, M.; Brunetti, L.; Stroud, C. R. G.; Walker, P. R.; Wang, K.; Chung, Y.; Ruppin, E.; Lee, S. -H.; Yang, L. V.; Pinato, D. J.; Lee, J. S.; Cortellini, A.
Efficacy of transarterial radioembolization using Y-90 resin microspheres versus atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: A matching-adjusted indirect comparison 1-gen-2024 Agirrezabal, I.; Bouattour, M.; Pinato, D. J.; D'Alessio, A.; Brennan, V. K.; Carion, P. L.; Shergill, S.; Amoury, N.; Vilgrain, V.
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours 1-gen-2024 Celsa, C.; Cabibbo, G.; Fulgenzi, C. A. M.; Scheiner, B.; D'Alessio, A.; Manfredi, G. F.; Nishida, N.; Ang, C.; Marron, T. U.; Saeed, A.; Wietharn, B.; Pinter, M.; Cheon, J.; Huang, Y. -H.; Lee, P. -C.; Phen, S.; Gampa, A.; Pillai, A.; Vivaldi, C.; Salani, F.; Masi, G.; Roehlen, N.; Thimme, R.; Vogel, A.; Schonlein, M.; von Felden, J.; Schulze, K.; Wege, H.; Galle, P. R.; Kudo, M.; Rimassa, L.; Singal, A. G.; El Tomb, P.; Ulahannan, S.; Parisi, A.; Chon, H. J.; Hsu, W. -F.; Stefanini, B.; Verzoni, E.; Giusti, R.; Veccia, A.; Catino, A.; Aprile, G.; Guglielmini, P. F.; Di Napoli, M.; Ermacora, P.; Antonuzzo, L.; Rossi, E.; Verderame, F.; Zustovich, F.; Ficorella, C.; Di Pietro, F. R.; Battelli, N.; Negrini, G.; Grossi, F.; Bordonaro, R.; Pipitone, S.; Banzi, M.; Ricciardi, S.; Laera, L.; Russo, A.; De Giorgi, U.; Cavanna, L.; Soraru, M.; Montesarchio, V.; Bordi, P.; Brunetti, L.; Pinto, C.; Bersanelli, M.; Camma, C.; Cortellini, A.; Pinato, D. J.
Treatment-emergent antidrug antibodies related to PD-1, PD-L1, or CTLA-4 inhibitors across tumor types: A systematic review 1-gen-2024 Galle, P.; Finn, R. S.; Mitchell, C. R.; Ndirangu, K.; Ramji, Z.; Redhead, G. S.; Pinato, D. J.
New Scenarios in Liver Transplantation for Hepatocellular Carcinoma 1-gen-2024 Mauro, E.; Rodriguez-Peralvarez, M.; D'Alessio, A.; Crespo, G.; Pinero, F.; Demartin, E.; Colmenero, J.; Pinato, D.; Forner, A.
Immunotherapy vs Best Supportive Care for Patients with Hepatocellular Cancer with Child-Pugh B Dysfunction 1-gen-2024 Fulgenzi, C. A. M.; Scheiner, B.; D'Alessio, A.; Mehan, A.; Manfredi, G. F.; Celsa, C.; Nishida, N.; Ang, C.; Marron, T. U.; Wu, L.; Saeed, A.; Wietharn, B.; Cammarota, A.; Pressiani, T.; Pinter, M.; Sharma, R.; Cheon, J.; Huang, Y. -H.; Lee, P. -C.; Phen, S.; Gampa, A.; Pillai, A.; Napolitano, A.; Vivaldi, C.; Salani, F.; Masi, G.; Silletta, M.; Lo Prinzi, F.; Di Giacomo, E.; Vincenzi, B.; Bettinger, D.; Thimme, R.; Vogel, A.; Schonlein, M.; Von Felden, J.; Schulze, K.; Wege, H.; Galle, P. R.; Pirisi, M.; Park, J. -W.; Kudo, M.; Rimassa, L.; Singal, A. G.; El Tomb, P.; Ulahannan, S.; Parisi, A.; Chon, H. J.; Hsu, W. -F.; Ghittoni, G.; Camma, C.; Stefanini, B.; Trevisani, F.; Giannini, E. G.; Cortellini, A.; Pinato, D. J.
Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysis 1-gen-2024 D'Alessio, A.; Stefanini, B.; Blanter, J.; Adegbite, B.; Crowley, F.; Yip, V.; Slater, S.; Fulgenzi, C. A. M.; Celsa, C.; Manfredi, G. F.; Pai, M.; Goldin, R. D.; Ward, S. C.; Fiel, M. I.; Shu, D. H.; Su, Y. -Y.; Cortellini, A.; Baretti, M.; Anders, R.; Yarchoan, M.; Hsu, C.; Marron, T. U.; Pinato, D. J.
Effects of immune checkpoint inhibitor associated endocrinopathies on cancer survival 1-gen-2024 Yang, L.; Murthy, S.; Cortellini, A.; Lim, E. A.; Gonzalez, M.; Pinato, D. J.; Abdel-Malek, M.; Mahmoud, S.; Martin, N. M.
Multidisciplinary Delphi Consensus on Safety of Combining Transarterial Radioembolization with Yttrium-90 Microspheres with Systemic Anticancer Agents for the Treatment of Liver Malignancy 1-gen-2024 Kennedy, A. S.; Brown, D. B.; Fakih, M.; Jeyarajah, R.; Jones, S.; Liu, D.; Pinato, D. J.; Sangro, B.; Sharma, N. K.; Sze, D. Y.; Van Cutsem, E.; Wasan, H. S.
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease 1-gen-2024 Luke, J. J.; Davar, D.; Andtbacka, R. H.; Bhardwaj, N.; Brody, J. D.; Chesney, J.; Coffin, R.; de Baere, T.; de Gruijl, T. D.; Fury, M.; Goldmacher, G.; Harrington, K. J.; Kaufman, H.; Kelly, C. M.; Khilnani, A. D.; Liu, K.; Loi, S.; Long, G. V.; Melero, I.; Middleton, M.; Neyns, B.; Pinato, D. J.; Sheth, R. A.; Solomon, S. B.; Szapary, P.; Marabelle, A.
Safety and efficacy of itacitinib, a selective JAK1 inhibitor, in advanced hepatocellular cancer: Phase 1b trial (JAKAL) 1-gen-2024 Troiani, A.; Martinez, M.; Ward, C.; Benartzi, C. W.; Pinato, D. J.; Sharma, R.
Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer 1-gen-2024 Hedayat, S.; Cascione, L.; Cunningham, D.; Schirripa, M.; Lampis, A.; Hahne, J. C.; Tunariu, N.; Hong, S. P.; Marchetti, S.; Khan, K.; Fontana, E.; Angerilli, V.; Delrieux, M.; Rodrigues, D. N.; Procaccio, L.; Rao, S.; Watkins, D.; Starling, N.; Chau, I.; Braconi, C.; Fotiadis, N.; Begum, R.; Guppy, N.; Howell, L.; Valenti, M.; Cribbes, S.; Kolozsvari, B.; Kirkin, V.; Lonardi, S.; Ghidini, M.; Passalacqua, R.; Elghadi, R.; Magnani, L.; Pinato, D. J.; Di Maggio, F.; Ghelardi, F.; Sottotetti, E.; Vetere, G.; Ciraci, P.; Vlachogiannis, G.; Pietrantonio, F.; Cremolini, C.; Cortellini, A.; Loupakis, F.; Fassan, M.; Valeri, N.
Safety and efficacy outcomes of early cessation of anti-PD1 therapy in patients 80 years or older: A retrospective cohort study 1-gen-2024 Fletcher, K.; Cortellini, A.; Ganta, T.; Kankaria, R.; Song, H.; Ye, F.; Irlmeier, R.; Debnath, N.; Saeed, A.; Radford, M.; Alahmadi, A.; Diamond, A.; Hoimes, C.; Presley, C. J.; Owen, D. H.; Abou Alaiwi, S.; Nassar, A. H.; Lamberti, G.; Perrone, F.; Buti, S.; Giusti, R.; Filetti, M.; Vanella, V.; Mallardo, D.; Sussman, T. A.; Galetta, D.; Kalofonou, F.; Daniels, E.; Ascierto, P. A.; Pinato, D. J.; Nebhan, C.; Berg, S.; Choueiri, T. K.; Marron, T. U.; Wang, Y.; Naqash, A. R.; Johnson, D. B.
Balancing Efficacy and Tolerability of First-Line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis 1-gen-2023 Celsa, C.; Cabibbo, G.; Pinato, D. J.; Di Maria, G.; Enea, M.; Vaccaro, M.; Battaglia, S.; Rizzo, G. E. M.; Giuffrida, P.; Giacchetto, C. M.; Rancatore, G.; Grassini, M. V.; Camma, C.
Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study 1-gen-2024 Pinato, D. J.; D'Alessio, A.; Fulgenzi, C. A. M.; Schlaak, A. E.; Celsa, C.; Killmer, S.; Blanco, J. M.; Ward, C.; Stikas, C. -V.; Openshaw, M. R.; Acuti, N.; Nteliopoulos, G.; Balcells, C.; Keun, H. C.; Goldin, R. D.; Ross, P. J.; Cortellini, A.; Thomas, R.; Young, A. -M.; Danckert, N.; Tait, P.; Marchesi, J. R.; Bengsch, B.; Sharma, R.
Spatial single-cell profiling and neighbourhood analysis reveal the determinants of immune architecture connected to checkpoint inhibitor therapy outcome in hepatocellular carcinoma 1-gen-2024 Salie, H.; Wischer, L.; D'Alessio, A.; Godbole, I.; Suo, Y.; Otto-Mora, P.; Beck, J.; Neumann, O.; Stenzinger, A.; Schirmacher, P.; Fulgenzi, C. A. M.; Blaumeiser, A.; Boerries, M.; Roehlen, N.; Schultheiss, M.; Hofmann, M.; Thimme, R.; Pinato, D. J.; Longerich, T.; Bengsch, B.
Outcome and management of patients with hepatocellular carcinoma who achieved complete response to immunotherapy-based systemic therapy 1-gen-2024 Scheiner, B.; Kang, B.; Balcar, L.; Radu, I. -P.; Reiter, F. P.; Adzic, G.; Guo, J.; Gao, X.; Yuan, X.; Cheng, L.; Gorgulho, J.; Schultheiss, M.; Peeters, F.; Hucke, F.; Ben Khaled, N.; Piseddu, I.; Philipp, A.; Sinner, F.; D'Alessio, A.; Pomej, K.; Saborowski, A.; Bathon, M.; Schwacha-Eipper, B.; Zarka, V.; Lampichler, K.; Nishida, N.; Lee, P. -C.; Krall, A.; Saeed, A.; Himmelsbach, V.; Tesini, G.; Huang, Y. -H.; Vivaldi, C.; Masi, G.; Vogel, A.; Schulze, K.; Trauner, M.; Djanani, A.; Stauber, R.; Kudo, M.; Parikh, N. D.; Dufour, J. -F.; Prejac, J.; Geier, A.; Bengsch, B.; von Felden, J.; Venerito, M.; Weinmann, A.; Peck-Radosavljevic, M.; Finkelmeier, F.; Dekervel, J.; Ji, F.; Wang, H. -W.; Rimassa, L.; Pinato, D. J.; Bouattour, M.; Chon, H. J.; Pinter, M.
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 2.921 a 2.940 di 35.986
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 1 Contributo su Rivista35985
  • 4 Contributo in Atti di Convegno ...1
Autore
  • ARNEODO, Michele1426
  • ARCIDIACONO, Roberta1411
  • RUSPA, Marta1323
  • GAIDANO, Gianluca764
  • RAMELLO, Luciano682
  • SITTA, Mario630
  • CORTESE, Pietro622
  • SACERDOTE, Carlotta545
  • Patti, Giuseppe Rocco Salvatore425
  • PIRISI, Mario410
Data di pubblicazione
  • In corso di stampa66
  • 2020 - 20269723
  • 2010 - 201913040
  • 2000 - 20097282
  • 1990 - 19994152
  • 1980 - 19891467
  • 1970 - 1979232
  • 1962 - 196924
Rivista
  • PHYSICS LETTERS. SECTION B771
  • JOURNAL OF HIGH ENERGY PHYSICS498
  • PHYSICAL REVIEW LETTERS295
  • THE EUROPEAN PHYSICAL JOURNAL. C,...284
  • PHYSICAL REVIEW D234
  • JOURNAL OF HIGH ENERGY PHYSICS183
  • PLOS ONE181
  • BLOOD169
  • INTERNATIONAL JOURNAL OF MOLECULA...163
  • NUCLEAR INSTRUMENTS & METHODS IN ...145
Keyword
  • Humans1437
  • Female757
  • Male607
  • Middle Aged459
  • Adult415
  • Aged406
  • COVID-19343
  • Italy297
  • Animals217
  • Treatment Outcome196
Lingua
  • eng24614
  • ita5280
  • fre259
  • spa169
  • ger57
  • rus29
  • und26
  • por17
  • lat15
  • grc6
Accesso al fulltext
  • no fulltext21340
  • reserved7308
  • open4914
  • restricted2307
  • partially open90
  • embargoed18
  • mixed9